相关实验视频
Updated: Sep 16, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
551
作为罕见皮肤恶性瘤的有效治疗方法的PD-1单克隆抗体:一个病例报告
Ryan Falk1, Wolfram Samlowski1,2,3, Amin Hedayat1,4,5
1Kirk Kerkorian School of Medicine, University of Nevada Las Vegas (UNLV), Las Vegas, NV, United States.
Frontiers in oncology
|July 9, 2025
概括
PD-1单克隆抗体对罕见的皮肤癌,如腺性瘤和眼皮脂质腺癌具有前途. 这些治疗导致了快速缓解,毒性最小,这表明未来临床试验的潜力.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫治疗是一种免疫疗法.
背景情况:
- 尾癌和状腺癌是罕见的皮肤恶性瘤.
- 局部治疗失败和化品/功能缺陷引起治疗挑战,特别是在围绕轨道区域.
- 检查点抑制剂,如 pembrolizumab 和 cemiplimab,已成为各种皮肤恶性瘤的治疗方法.
关键词:
状腺癌 (Adenosquamous Carcinoma) 是一种状腺癌.附带性癌细胞瘤是什么在Cemiplimab,我们可以看到.检查点抑制剂的检查点抑制剂这就是Pembrolizumab.脂质癌细胞瘤是什么更多相关视频
相关概念视频
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K

